Chicago Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.04M | Sell |
2,878
-186
| -6% | -$63.7K | 0.15% | 138 |
|
|
2026
Q1 | $1.08M | Sell |
3,064
-83
| -3% | -$29.6K | 0.17% | 119 |
|
|
2025
Q4 | $1.03M | Sell |
3,147
-5
| -0.2% | -$1.59K | 0.16% | 114 |
|
|
2025
Q3 | $889K | Sell |
3,152
-4,824
| -60% | -$1.4M | 0.12% | 149 |
|
|
2025
Q2 | $2.23M | Buy |
7,976
+479
| +6% | +$136K | 0.31% | 73 |
|
|
2025
Q1 | $2.34M | Sell |
7,497
-161
| -2% | -$47.5K | 0.41% | 61 |
|
|
2024
Q4 | $2M | Buy |
7,658
+8
| +0.1% | +$2.37K | 0.35% | 72 |
|
|
2024
Q3 | $2.46M | Sell |
7,650
-117
| -2% | -$38.3K | 0.43% | 59 |
|
|
2024
Q2 | $2.43M | Sell |
7,767
-720
| -8% | -$212K | 0.49% | 49 |
|
|
2024
Q1 | $2.41M | Buy |
8,487
+513
| +6% | +$150K | 0.5% | 50 |
|
|
2023
Q4 | $2.3M | Sell |
7,974
-116
| -1% | -$31.6K | 0.51% | 50 |
|
|
2023
Q3 | $2.17M | Buy |
8,090
+215
| +3% | +$53.7K | 0.55% | 49 |
|
|
2023
Q2 | $1.75M | Buy |
7,875
+216
| +3% | +$50.1K | 0.42% | 62 |
|
|
2023
Q1 | $1.85M | Sell |
7,659
-1,139
| -13% | -$280K | 0.46% | 52 |
|
|
2022
Q4 | $2.31M | Buy |
8,798
+482
| +6% | +$129K | 0.58% | 46 |
|
|
2022
Q3 | $1.88M | Sell |
8,316
-202
| -2% | -$49K | 0.49% | 53 |
|
|
2022
Q2 | $2.07M | Buy |
8,518
+620
| +8% | +$152K | 0.52% | 53 |
|
|
2022
Q1 | $1.91M | Sell |
7,898
-199
| -2% | -$45.7K | 0.41% | 65 |
|
|
2021
Q4 | $1.82M | Sell |
8,097
-80
| -1% | -$16.9K | 0.36% | 80 |
|
|
2021
Q3 | $1.74M | Sell |
8,177
-635
| -7% | -$146K | 0.38% | 75 |
|
|
2021
Q2 | $2.15M | Buy |
8,812
+5,603
| +175% | +$1.38M | 0.51% | 53 |
|
|
2021
Q1 | $798K | Sell |
3,209
-413
| -11% | -$98.5K | 0.27% | 100 |
|
|
2020
Q4 | $833K | Buy |
3,622
+199
| +6% | +$45.9K | 0.29% | 96 |
|
|
2020
Q3 | $870K | Buy |
3,423
+49
| +1% | +$12.1K | 0.36% | 83 |
|
|
2020
Q2 | $796K | Buy |
3,374
+100
| +3% | +$22.8K | 0.35% | 81 |
|
|
2020
Q1 | $664K | Sell |
3,274
-70
| -2% | -$15.3K | 0.34% | 82 |
|
|
2019
Q4 | $807K | Sell |
3,344
-155
| -4% | -$34.2K | 0.33% | 82 |
|
|
2019
Q3 | $677K | Sell |
3,499
-217
| -6% | -$41.7K | 0.29% | 94 |
|
|
2019
Q2 | $685 | Buy |
3,716
+100
| +3% | +$17.9K | 0.29% | 95 |
|
|
2019
Q1 | $687 | Sell |
3,616
-100
| -3% | -$19.1K | 0.3% | 90 |
|
|
2018
Q4 | $723 | Hold |
3,716
| – | – | 0.34% | 77 |
|
|
2018
Q3 | $771K | Sell |
3,716
-75
| -2% | -$14.8K | 0.31% | 84 |
|
|
2018
Q2 | $700K | Sell |
3,791
-1,487
| -28% | -$263K | 0.3% | 85 |
|
|
2018
Q1 | $900K | Sell |
5,278
-8,581
| -62% | -$1.58M | 0.38% | 69 |
|
|
2017
Q4 | $2.41M | Sell |
13,859
-189
| -1% | -$33.4K | 0.96% | 42 |
|
|
2017
Q3 | $2.62K | Sell |
14,048
-2,633
| -16% | -$467K | 1.1% | 32 |
|
|
2017
Q2 | $2.87K | Sell |
16,681
-141
| -0.8% | -$22.9K | 1.28% | 27 |
|
|
2017
Q1 | $2.76K | Sell |
16,822
-1,683
| -9% | -$280K | 1.22% | 25 |
|
|
2016
Q4 | $2.71M | Buy |
18,505
+2,167
| +13% | +$326K | 1.17% | 23 |
|
|
2016
Q3 | $2.73M | Sell |
16,338
-279
| -2% | -$47.2K | 1.19% | 26 |
|
|
2016
Q2 | $2.53M | Sell |
16,617
-285
| -2% | -$44.3K | 1.04% | 30 |
|
|
2016
Q1 | $2.53M | Buy |
16,902
+590
| +4% | +$87.7K | 1.05% | 29 |
|
|
2015
Q4 | $2.65M | Buy |
16,312
+3,465
| +27% | +$545K | 1.03% | 26 |
|
|
2015
Q3 | $1.78M | Buy |
12,847
+4,714
| +58% | +$743K | 0.68% | 49 |
|
|
2015
Q2 | $1.25M | Buy |
8,133
+1,064
| +15% | +$170K | 0.44% | 71 |
|
|
2015
Q1 | $1.13M | Buy |
+7,069
| New | +$1.11M | 0.39% | 80 |
|
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
Chicago Trust's AMGN Position: Q2 2026 in Review
Chicago Trust reduced its Amgen (AMGN) stake by 6.1% in Q2 2026, selling an estimated $63.7K and leaving 2,878 shares worth $1.04M. The position accounts for 0.15% of the portfolio, ranked #138.
Chicago Trust first reported a position in AMGN in Q1 2015 and has held it in 46 quarters since. The position peaked at $2.73M in Q3 2016. 687 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Chicago Trust held 2,878 shares of Amgen worth $1.04M as of Q2 2026.
- Chicago Trust sold 186 Amgen shares in Q2 2026, an estimated $63.7K.
- Amgen made up 0.15% of Chicago Trust's portfolio in Q2 2026, its #138 holding.
- Chicago Trust first reported a position in Amgen in Q1 2015 and has held it in 46 quarters since.
- Chicago Trust's Amgen position peaked at $2.73M in Q3 2016.
- 687 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.